Compensated cirrhosis describes the stage of cirrhosis in which a person is not experiencing any symptoms. In severe cases, it can progress to decompensated cirrhosis. Cirrhosis is a progressive ...

These features make lamivudine a more appropriate treatment compared with IFN for patients with decompensated HBV cirrhosis. The recommended dose of lamivudine is 100 mg daily. Because lamivudine ...

Keep reading below to learn more about how cirrhosis leads to ascites. We’ll also discuss symptoms to know about, the risks associated with ascites, and how ascites is treated. In cirrhosis ...

Sarcopenia is a common complication of decompensated cirrhosis resulting in progressive loss of muscle mass and function. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Background and Aim: The natural history of alcoholic cirrhosis, especially in Asian ... P = 0.0003), while the cumulative rates of hepatic decompensation (37.4% vs 51.7% at 10 years) and survival ...

According to National Institutes of Health, decompensated cirrhosis is an acute deterioration in liver function in a patient with cirrhosis. Fast Track Designation provides several benefits including ...

Patients with decompensated cirrhosis and sarcopenia exhibit significantly ... for oral administration targeted for the management of symptoms associated with liver cirrhosis.

LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...

Patients with decompensated cirrhosis and sarcopenia exhibit significantly shorter ... a novel androgen receptor agonist prodrug for oral administration targeted for the management of symptoms ...